- Safety and Tolerability of Docetaxel, Cyclophosphamide, and Trastuzumab Compared to Standard Trastuzumab-Based Chemotherapy Regimens for Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
-
Jitawatanarat P, O'Connor T, Kossoff EB, Levine EG, Chittawatanarat K, Ngamphaiboon N
- KMID: 2176127
- J Breast Cancer.
- 2014 Dec;17(4):356-362.
- doi: 10.4048/jbc.2014.17.4.356
PURPOSE: We evaluated the tolerability and cardiac safety of docetaxel, cyclophosphamide, and trastuzumab (TCyH) for the treatment of early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer and compared... -
- CITED
-
- Close
- SHARE
-
- Close
